New York State Common Retirement Fund increased its holdings in Safeguard Scientifics, Inc (NYSE:SFE) by 40.4% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 199,109 shares of the asset manager’s stock after buying an additional 57,295 shares during the period. New York State Common Retirement Fund owned 0.98% of Safeguard Scientifics worth $2,658,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the stock. Vanguard Group Inc. increased its stake in Safeguard Scientifics by 1.9% in the first quarter. Vanguard Group Inc. now owns 828,897 shares of the asset manager’s stock valued at $10,528,000 after acquiring an additional 15,086 shares during the last quarter. State Street Corp increased its stake in Safeguard Scientifics by 7.9% in the second quarter. State Street Corp now owns 383,000 shares of the asset manager’s stock valued at $4,558,000 after acquiring an additional 28,161 shares during the last quarter. Prudential Financial Inc. increased its stake in Safeguard Scientifics by 60.7% in the second quarter. Prudential Financial Inc. now owns 27,281 shares of the asset manager’s stock valued at $325,000 after acquiring an additional 10,300 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Safeguard Scientifics by 6.6% in the second quarter. Dimensional Fund Advisors LP now owns 1,147,008 shares of the asset manager’s stock valued at $13,649,000 after acquiring an additional 71,379 shares during the last quarter. Finally, Goodman Financial Corp increased its stake in Safeguard Scientifics by 9.0% in the third quarter. Goodman Financial Corp now owns 330,556 shares of the asset manager’s stock valued at $4,413,000 after acquiring an additional 27,340 shares during the last quarter. Institutional investors own 76.30% of the company’s stock.
Safeguard Scientifics, Inc (NYSE SFE) opened at $11.15 on Friday. Safeguard Scientifics, Inc has a 12 month low of $10.65 and a 12 month high of $14.40. The stock has a market capitalization of $224.54, a PE ratio of -2.48 and a beta of 1.30. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.03 and a current ratio of 1.03.
Safeguard Scientifics (NYSE:SFE) last announced its quarterly earnings data on Thursday, October 26th. The asset manager reported ($0.91) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($1.11) by $0.20. During the same period in the prior year, the firm earned ($1.18) EPS. sell-side analysts anticipate that Safeguard Scientifics, Inc will post -4.47 EPS for the current fiscal year.
A number of research analysts recently commented on SFE shares. Zacks Investment Research raised Safeguard Scientifics from a “sell” rating to a “hold” rating in a research note on Thursday, September 28th. ValuEngine cut Safeguard Scientifics from a “hold” rating to a “sell” rating in a research note on Tuesday, November 14th. Finally, Keefe, Bruyette & Woods reissued a “mkt perform” rating and issued a $13.25 target price on shares of Safeguard Scientifics in a research note on Wednesday, December 6th.
COPYRIGHT VIOLATION WARNING: This report was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/01/14/new-york-state-common-retirement-fund-grows-holdings-in-safeguard-scientifics-inc-sfe.html.
About Safeguard Scientifics
Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.